If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:129453-61-8
Source:Europe
Qualifications:USDMF/-/-/-/-
Name | Fulvestrant |
---|---|
Chinese name | 氟维司群 |
Cas Number | 129453-61-8 |
Source | Europe |
Qualifications | USDMF/-/-/-/- |
This product is a new class of estrogen receptor antagonists-estrogen receptor down-regulators anti-breast cancer treatment drugs. Since estrogen receptors (ER) are found in many breast cancer patients, and tumor growth is stimulated by estrogen, the current main method of treatment of breast cancer is to reduce the concentration of estrogen. The effect of the drug shows the characteristics of targeted therapy. Fulvestrant provides a new endocrine therapy drug choice for patients with advanced postmenopausal breast cancer. It is safe and well tolerated, and prolongs the patient’s benefit from endocrine therapy. time.
Hot Tags: fulvestrant api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Escitalopram Oxalate API, Bemeprost API, Edoxaban API, Aprepitant Aprepitant API, Pazopanib Hydrochloride Pazopanib API, Bosentan API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China